Gilead Sciences

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The enterprise transformed the management of viral diseases by developing standard-of-care HIV therapies like Biktarvy and curative hepatitis C treatments, while expanding into oncology through cell therapies via Kite Pharma. Through antiviral drug design and clinical research, Gilead Sciences delivers medical therapies for life-threatening diseases worldwide.